Becton, Dickinson and Co. | BDX - Net Income


Becton, Dickinson and Co. reported $-311M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Abbott USD 1.08B 699M Mar/2026
Agilent USD 339M 34M Mar/2026
Align Technology USD 112.77M 22.99M Mar/2026
AngioDynamics USD -6.35M 4.55M Sep/2025
Avanos Medical USD 5.1M 6.4M Mar/2026
Baxter International USD -15M 1.11B Mar/2026
Becton, Dickinson and Co. USD -311M 693M Mar/2026
Bio-Rad Laboratories USD 720M 1.06B Dec/2025
Boston Scientific USD 1.34B 669M Mar/2026
Cooper Companies USD -77.9M 208.7M Mar/2026
Danaher USD 1.03B 168M Mar/2026
Dentsply International USD -10M 136M Mar/2026
Dexcom USD 199.5M 67.8M Mar/2026
Edwards Lifesciences USD 380.7M 289.5M Mar/2026
Globus Medical USD 140.59M 21.63M Dec/2025
Insulet USD 91.1M 10.5M Mar/2026
Integra LifeSciences USD -4.62M 2.91M Mar/2026
Intuitive Surgical USD 821.5M 26.7M Mar/2026
J&J USD 5.24B 119M Mar/2026
Masimo USD 57.1M 11.2M Mar/2026
Medtronic USD 1.24B 100M Mar/2026
Solventum Corp USD 13M 50M Mar/2026
Stryker USD 745M 104M Mar/2026
Tandem Diabetes Care USD -589K 20.58M Dec/2025
Teleflex USD -8.15M 706.18M Mar/2026
Terumo JPY 26.37B 6.28B Mar/2026
Thermo Fisher Scientific USD 1.65B 313M Mar/2026
Zimmer Biomet Holdings USD 238.1M 98.8M Mar/2026